View all veterinary jobs
The clinic, which is led by RCVS Recognised Specialists in Small Animal Orthopaedics, Andy Moores and Chris Jordan, focuses on delivering affordable care and supporting general practitioners.
Last year, the team sent over 900 free advice emails to UK vets who had asked for guidance.
Clinical Director Andy Moores said: "We would like to thank all of our referring vets for their ongoing support and for putting their trust in us.
"Our goal at The Moores Orthopaedic Clinic has always been to provide excellent, affordable care, and I am pleased to say that we deliver that day in day out."
He added: "We are in a unique situation at The Moores Orthopaedic Clinic, whereby our veterinary team consists solely of RCVS Specialist surgeons.
"This allows us to be efficient and offer great value TPLOs and hip replacements for example but also to offer cutting-edge services such as 3rd generation TATE elbow replacements and be entirely confident in the level of service we provide.
"We are supported by our incredible nursing team and support staff who all have a deep knowledge and understanding of orthopaedic issues in pets."
For case advice, email: info@mooresortho.com
www.mooresortho.com
For the research, published in Osteoarthritis and Cartilage, the team studied osteoarthritic tissues from dogs with osteoarthritis treated with total hip replacement surgery at the RVC's Queen Mother Hospital for Animals, using ultra-high-resolution micro-computed tomography to map the entire femoral head in three dimensions.
Using this technique, as opposed to more localised analysis previously conducted on human samples, researchers identified that different areas of the femoral head simultaneously responded differently.
In particular, the findings revealed that in the earliest stages of osteoarthritis, the inner regions predictably change their bone structure pattern, allowing early identification of osteoarthritis.
As the disease progresses, the dense layer of bone immediately below the joint surface becomes more porous in proportion to the increasing severity of osteoarthritis, distinguishing mild from severe changes.
The researchers say that the next step is to match these changes with clinical scans to develop improved non-invasive approaches to assessing joint health at much earlier stages of disease.
Professor Richard Meeson, Professor of Orthopaedics at the RVC, and senior author of the paper, said: "Osteoarthritis is a devastating disease affecting both people and our pets.
"Every day in our orthopaedic referral clinic, I see dogs suffering from its severe effects.
"What is truly exciting is that through our clinical work, we can transform the lives of dogs through hip replacement surgery, and we have also been able to drive forward pioneering research at the RVC.
"This research has provided new insights into the disease and, crucially, brings us closer to diagnosing osteoarthritis at a much earlier stage."
Reference
CrCLD has previously been suggested to be associated with gonad status, but there has been no clear consensus on how “early” gonadectomy should be defined in male or female dogs.
The study carried out a secondary analysis of data from more than 20,000 dogs spanning 36 years to explore the association between cumulative gonadal hormone exposure and risk of CrCLD.
Rather than categorising dogs using arbitrary age cut-offs, the researchers treated gonadal hormone exposure as a continuous variable.
In the dataset analysed, the prevalence of CrCLD was 2.49% in females and 1.89% in male dogs.
The risk of CrCLD was highest in dogs with the least gonadal hormone exposure — before 1054 days (approximately 2.9 years) in females and 805 days (approximately 2.2 years) in males.
The minimum risk was observed at around 2.9 years for females and 2.2 years for males.
The authors say that these findings suggest gonadectomy is very likely to be associated with an increased risk of CrCLD, and that previously suggested arbitrary cut-offs of two years of age may not be scientifically grounded.
Overall, the paper concluded that removal of gonadal hormones should be performed after musculoskeletal maturity, if at all.
Lead author Dr Daniel Low said there is an increasing body of evidence linking the development of CrCLD with neutering in both male and female dogs, and that the timing of neutering matters.
He added that the health benefits of neutering in reducing the risk of other diseases should not be overlooked, and that every decision to neuter should be made on a case-by-case basis by the attending veterinary surgeon in consultation with the animal owner.
The three factsheet chapters cover understanding OA, creating a management plan and supporting pets and their owners.
Krka says each section is grounded in evidence-based approaches and was shaped by Professor Carmichael’s extensive knowledge of the pathogenesis of pain in patients with OA and experience in the diagnosis, contextualised treatment, and long-term care of patients with OA.
The resources encourage veterinary teams to adapt their approach to the needs of each case - supporting a flexible, patient-centred mindset in everyday consults.
Stuart said: “What works is the thing that works best for the dog, the owner and the practice in that moment.
“And part of the art is trying to get that right rather than being dogmatic about a certain type of treatment.”
Renzo Di Florio, Krka’s Technical Veterinary Adviser, said: “In first-opinion practice, consult time is limited and there’s a lot to cover.
"These factsheets bring together expert advice in a format that’s quick to reference and easy to apply in consults.
"They’re designed to help vets feel more confident in their approach to OA, especially when time is tight.”
To further support veterinary professionals in managing OA, Professor Carmichael has delivered a webinar, available here: https://membership.elearning.vet/rethinking-canine-oa-login.
He and Renzo will also be presenting together at the London Vet Show this November, delivering a session focused on osteoarthritis in practice on Thursday 20th November at 14.00 in Exhibitor Showcase Theatre 2.
The OA factsheets are available here: https://www.krka.co.uk/veterinary-knowledge-hub/
Joint Care contains glucosamine, rosehip, echinacea, and vitamin C, and Supreme Petfoods says it's been developed in response to growing awareness of osteoarthritis (OA) as a significant yet under-diagnosed condition in small mammals.
Supreme points to a retrospective study which identified osteoarthritic lesions in 40% of domestic rabbits, with prevalence strongly correlated with age and body weight.¹
The company says that while definitive prevalence data in guinea pigs is lacking, OA is considered to be common in this species as well.²
Molly Varga, RCVS recognised exotics specialist, said: “Signs of joint pain are often subtle or masked in prey species.
"Proactive use of nutritional supplements like Science Selective Joint Care can help maintain mobility and may delay progression.
"Nutritional support, combined with appropriate husbandry and veterinary care, can make a real difference to long-term quality of life.”
As well as glucosamine, Science Selective Joint Care also contains rosehip, a botanical with claimed anti-inflammatory and chondroprotective properties and echinacea, which has claimed anti-inflammatory, antioxidant and immunomodulatory activity.3,4
Supreme says Vitamin C is an essential nutrient for guinea pigs and beneficial for rabbits, and contributes to normal collagen formation and may help protect joint tissues from oxidative stress.
Claire Hamblion, Marketing Director at Supreme Petfoods, said: “With 45% of pet owners now regularly purchasing supplements for their animals,5 the demand for clinically relevant, species-appropriate products is growing.
"We work closely with veterinary and nutrition experts to ensure our formulations meet emerging needs and Joint Care reflects that commitment.”
Available in 100g packs, Joint Care has a recommended retail price (RRP) of £6.99 and is suitable for rabbits, guinea pigs, and chinchillas.
https://supremepetfoods.com/products/science-selective-care-supplements
References
There are four events: two webinars, a face-to-face event with a workshop and a presentation at this year’s BVNA Congress.
The first webinar: ‘OA pain, awareness and management: how veterinary teams can collaborate to effectively manage OA’, takes place on Thursday 7th August (7-8pm).
The second webinar: ‘Librela clinical update; 4 years of clinical experience’ is on Tuesday 19th August (7-8pm).
The face-to-face event: ‘OA pain, awareness and management: how veterinary teams can collaborate to effectively manage OA’ and ‘Librela clinical update; 4 years of clinical experience’ plus practical application workshops, is on Saturday 6th September (10am-1pm) at BVNA HQ Harlow, Essex.
Finally, the BVNA Congress presentation: ‘The Joint Approach; the importance of the nursing team in OA diagnosis and management is on Sunday 12th October (9-10am) and it is free for everyone.
Jayne Clark, Zoetis National Veterinary Manager, Pain. “We are aiming for the talks to enhance delegates’ confidence in navigating aspects of pain management in dogs and cats so that they can support pet and owners with the latest knowledge, in a highly informed, confident and objective way.”
https://bvna.org.uk/events
Topics include the pathogenesis of OA, the importance of personalised treatment plans, and practical tips for supporting both pets and caregivers.
The first podcast centres around understanding the pathogenesis of the condition and the importance of thorough clinical examinations, diagnostic imaging and early intervention, all of which can greatly influence long-term outcomes.
Stuart said: “We often see pain as a problem, but it’s also a signal that gives us the opportunity to act early and prevent further progression.
"By the time pain is obvious, the disease is often so advanced that our ability to make a meaningful impact is limited.
"Acting early can change this pattern, and that’s a critical message we need to communicate to pet owners.”
Stuart is joined in the series by Krka’s technical veterinary adviser, Renzo Di Florio.
In subsequent episodes they share their thoughts on the latest advances in osteoarthritis treatment, creating an effective management plan that is individualised for each patient and tips for engaging with caregivers.
Renzo said: “Our goal with this podcast series is to empower veterinary professionals - whether they are new graduates or experienced practitioners - with evidence-based knowledge they can trust and apply.
"We’re excited to share these insights and have more planned for 2025, so stay tuned!”
https://open.spotify.com/show/0uphORU03q29WncwmN2EIa
The company points to research which shows that osteoarthritis can affect up to 40% of dogs 1,2 and managing the disease requires a multi-faceted 1,3, life-long, approach.
Animalcare says its osteoarthritis diary gives practices a practical, client-friendly tool to engage pet owners in their dog’s care journey, promoting adherence to treatment plans and enhancing communication between vets and pet owners.
Pet owners are asked to record three everyday activities to monitor their dog's progress, for example, its ability to get into the car, go upstairs or get up after sleeping, on a scale of 1-4.
This will allow all members of the veterinary team to understand how the patient is responding to treatment.
Kai Crawshaw, Brand Manager at Animalcare said: “This OA Diary is intended to enhance the veterinary practice’s ability to offer comprehensive, contextualised care, without increasing their workload.
"The diary supports both initial treatment plans and long-term management strategies, giving veterinary staff confidence that their patients are receiving the ongoing care they need at home.”
https://www.animalcare.co.uk/oa_diary/
For the study1, which was conducted from March 2011 to August 2021, the cases of 50 puppies aged 3 to 6 months with unicondylar fractures were reviewed.
The sample included 30 fractures in 29 dogs treated with transcondylar bone screws and K-wires.
All fractures healed successfully.
The study included 24 male and 26 female puppies, with French Bulldogs representing 50% of the cases, ages ranging from 11 to 30 weeks and bodyweight varying from 1.5 to 16.9 kg, with a median of 5.5 kg.
Short-term outcomes were excellent in 77% of cases and good in 23%.
No catastrophic failures occurred, and the four complications encountered were resolved with further minor surgery.
The author says that while recent studies have raised concerns about the stability of using K-wires, rather than bone plates, this one suggests that for puppies at least, the combination of a transcondylar bone screw and K-wire is effective.
The incidence of implant-related complications was lower than in adult dogs, and the short-term outcomes were excellent or good in all cases with follow-up data.
The research underscores the need for further multicentre studies with longer-term follow-up to confirm these findings and compare them with other fixation techniques.
However, this study concludes that while epicondylar plates have become accepted practice for adult dogs with such fractures, they may not be necessary for puppies aged 3 to 7 months.
Study in full: https://cgrp01mstr8u1x2prod.dxcloud.episerver.net/globalassets/stock-images/humeral-condylar-paper---weighbridge-referral-centre---cvs.pdf
www.weighbridgevets.co.uk
The original TATE elbow replacement was first in clinical use in the 2010s and the revised 3rd generation version is apparently a much-improved implant, something which the clinical evaluation trial should demonstrate.
Andy Moores, head of the joint replacement programme at The Moores Orthopaedic Clinic, said: “Canine elbow replacement can be a game-changer for dogs living with chronic elbow pain but up until this point the elbow replacement systems have not been as reliable as we would like.
"The third-generation TATE implant has been in use with a small number of US surgeons for several years now and the results so far have been very promising.
"We are delighted that Biomedtrix have invited us to join the evaluation trial for this implant and that the RCVS Ethics Review Panel have approved this.
"We look forward to offering this surgery as an option for some of our most painful canine patients.”
Canine Arthritis Management says the service is designed to help address issues with the traditional veterinary care approach, such as short consult times, significant workplace pressure and lack of understanding of the caregiver.
The service offers expert consultations through which veterinary professionals and other caregivers can confer with a dedicated team of experts in canine arthritis for the latest insights and treatment strategies.
The telehealth service can also supplement the veterinary consultation, giving extra time to create personalised care plans for clients, tailored to their dog's specific needs.
Canine Arthritis Management says its care plans are designed with a holistic approach, considering not only the medical requirements of the dog but also its living environment and lifestyle.
Canine Arthritis Telehealth also offers ongoing support and educational resources.
Canine Arthritis Management Founder, Hannah Capon MRCVS said: “One of the biggest misunderstandings surrounding osteoarthritis is that it is simple to manage.
"It is not.
"The long term, waxing and waning nature of the disease, combined with the financial and physical commitments, leads to emotional exhaustion for the caregiver.
"Combining this with a lack of understanding of the disease, confusion regarding the myriad of ways to address it, and anxiety surrounding the future, caregivers of animals with chronic disease need more support, and that is exactly what this service offers.”
caninearthritisteleguidance.co.uk
Each event is designed to help attendees with:
Each attendee will be given a complimentary annual Veterinary Osteoarthritis Alliance (VOA) membership.
Kai Crawshaw, Animalcare Brand Manager said: "We had excellent feedback from our first workshops, so we’re pleased to be able to reach veterinary practices in more locations around the UK.
"We also have plans to run more across the rest of the year.
"We hope that these events will lead to veterinary staff becoming more confident in dealing with OA in dogs and helping owners understand the options open to them."
All events start at 7:30pm (arrival from 7pm) and will finish approximately at 9:30pm.
Hot food and drinks will be provided.
https://www.animalcare.co.uk/oa-workshops
Congress offers two days of lectures and workshops and up to 14 hours CPD delivered by experts on the most cutting-edge OA management, treatment, techniques and technology.
There is also a large trade exhibition showcasing many of the latest products and services, not to mention a happy hour and gala dinner.
The organisers say veterinary surgeons and nurses, physiotherapists, hydrotherapists, and anyone working to prevent, treat and manage osteoarthritis will find the congress hugely rewarding.
This year there’s a focus on comparative disciplines, including human and equine practice.
Tickets cost from £190 to £370, plus VAT.
www.vet-oa.com/voacon
The study was based on VetCompass anonymised clinical records from more than two million dogs under first opinion veterinary care in the UK in 2019.
The study applied causal inference methods to the analysis of random samples of 815 dogs with CCL rupture aged between 1.5- and 12-years-old to replicate a randomised clinical trial and explore the impact of the different treatment methods.
Balancing the arms of the study for variables including age, breed and bodyweight, the researchers compared the outcomes for the dogs who received surgical management for CCL ruptures to those that were managed non-surgically.
The results showed that dogs managed surgically were 25.7% less likely to show short-term lameness at 3 months post-diagnosis and 31.7% less likely to show long-term lameness at 12 months post-diagnosis than dogs managed non-surgically.
Surgically managed dogs were 38.9% less likely to have a pain relief prescription at 3 months post-diagnosis, 34.1% less likely at 6 months and 32.7% less likely at 12 months than dogs managed non-surgically.
The RVC says these findings also similarly demonstrate lower longer term pain in surgically managed dogs.
Camilla Pegram, VetCompass PhD student at the RVC and lead author of the paper, said: “This study used an exciting new approach that allowed us to determine ‘cause’ rather than being limited to ‘association’.
"Surgical management for CCL rupture is often considered as providing better outcomes than non-surgical management, but this study now provides an evidence base to support this.
"Whilst surgical management might not always be feasible for some dogs, the findings allow vets to quantify the benefit in their discussions with owners.”
https://doi.org/10.1016/j.prevetmed.2024.106165
Cranial cruciate ligament insufficiency (CCLI) affects 3% to 5% of dogs1.
Past research has demonstrated satisfactory short (6-12 weeks)2 and medium (mean 16 months)3 term outcomes for lame dogs treated with TTA.
However, Steve says there is limited research on longer (>16 months) follow-up periods.
It has also been speculated that dogs with tibial plateau angles (TPA) of greater than 30⁰ are not well suited for a TTA4.
For the study5, the researchers reviewed patient records for a total of 149 TTA-Rapid procedures carried out in 120 dogs over an 80 month period.
They also reviewed owner questionnaires that evaluated the outcome of at least six months after surgery, using a validated clinical metrology instrument, Liverpool Osteoarthritis in Dogs (LOAD).
Follow-up questionnaires were received from owners of 64 of the 120 dogs (53.3%), with a median follow-up time of 37.5 months.
This cohort included a wide range of breeds, aged between 2&12 years and with bodyweights ranging from 6.3 to 41.8kg.
The dogs included 37 females and 27 males, and of the 79 limbs treated in these dogs, 41 were left and 38 were right.
The researchers found 26 of the dogs (40.6%) had a TTA performed with a TPA less than 30◦ and 38 (59.4%) with a TPA of 30◦ or more.
Of the 79 procedures, meniscal injury was noted in 27 (34.2%), surgery to stabilise the patella was required in 11 (13.9%), there was one surgical site infection (treated successfully with a short course of antibiotics), one dog sustained a fracture of the tibial seven days after surgery, and one sustained a late meniscal tear 12 months after initial surgery (treated successfully by partial meniscectomy).
The outcome was judged to be satisfactory, based on frequency of lameness, in 63 (98.4%), while satisfactory outcomes were achieved in 61 (95.3%) based on severity of lameness and in 50 (78.1%) based on mobility score.
Statistical analysis showed that age, bodyweight, tibial plateau angle (TPA), meniscal injury, and concurrent patellar surgery did not influence the outcome, but time to follow-up positively correlated with mobility score (suggesting mobility declined with time from surgery).
The researchers concluded that the long-term (median of 37.5 months) outcome for dogs undergoing TTA-Rapid for cranial cruciate ligament disease is satisfactory, with no risk factors associated with poorer outcomes identified.
The study also revealed no evidence to support the suggestion that dogs with TPAs of greater than 30◦ may be inappropriate candidates for TTA - after testing several parameters to judge outcome including frequency of lameness, severity of lameness, distance walked daily and mobility score.
Steve said: “This research is important in trying to ensure that decisions on whether to use this treatment modality, are based on sound clinical evidence.
"The only factor identified that influenced the outcome measure was that of time since surgery.
"All other factors, including TPA, had no effect on the outcome.”
The group says it has led to 6,086 more clinical metrology questionnaires being conducted at participating practices with their patients, a 1,014% increase.
Developed by John Innes at the University of Liverpool, the Liverpool Osteoarthritis in Dogs (LOAD) questionnaire is a 13-item clinical metrology instrument (CMI) used to assess canine articular disorders like osteoarthritis.
It includes questions on the pets’ medical background, lifestyle and mobility.
Individual question scores are summed to provide an overall “LOAD score” suggestive of the animal’s disease presence and severity.
The questionnaire should be conducted every time the pet is presented to the veterinary clinic, with results tracked over time.
Treatment options - including the benefits and risks of all available modalities – can then be considered and discussed with owners to determine the best course of action, including weight management, diet, supplements, exercise and environmental modification, in addition to medication.
As part of the project, CVS provided a range of supporting resources for its practices, together with training.
Training focussed on diagnosing and managing conditions causing lameness in dogs and cats, using the clinical metrology questionnaire to engage clients in their pets’ treatment plan, offering best practice treatment options and running nurse mobility clinics.
It comprised of a vet CPD day run with Zoetis and the VOA on approach to and management of lame patients, two nurse CPD days on mobility clinics, a feline and canine orthopaedic examination video, First Opinion Clinical Club webinars on canine and feline osteoarthritis and an approach to radiographic interpretation course.
Resources included: new clinical guidelines, IMV resources (radiographic positioning, optimising the image and optimal chemical restraint) and a Mobility Clinic Booklet for clients.
Each site was then provided with its own data, so that they could monitor what they were doing individually.
One year after its nation-wide launch, results reveal that the number of clinical metrology questionnaires being conducted in the 35 participating practices has increased from 6 to 6,092 over a 12 month time period.
CVS says there was also evidence of an increasing incidence of the osteoarthritis drugs Librela and Solensia being prescribed.
Kathryn Patel, Hub Clinical Lead at CVS (pictured), who was responsible for the lameness clinical improvement project, said: “This project uses owner questionnaires to screen for and monitor the impact of lameness on patient quality of life and emphasises the importance of the whole clinical team in patient management.
"Vets and nurses will be supported to improve their ability to reach a diagnosis in every lame case, improve engagement with and compliance of owners with lame pets, and improve the quality of care of lame patients through appropriate medication, surgical intervention, and nurse and physiotherapy support.”
For his research, Hugo visited the La Brea museum in Los Angeles, which gave him permission to study its collection of skeletal remains found in the La Brea tar pits.
“During my first visit, I concentrated on stifle diseases like cranial cruciate ligament rupture, which are very common in our modern-day dog companions.
"But in addition to cruciate disease, I also found OCD (osteochondritis dissecans) defects in the stifles and shoulders – which is again very common in modern dogs."
"My second visit was more focused on the changes in the spine of the dire wolf and the Sabre-toothed cat.”
"Some dire wolves had cruciate ligament ruptures, but it was uncommon compared to the most affected dog breeds.
"This is very similar to modern-day grey wolves which also suffer rarely from cruciate damage.
"In contrast, the prevalence of stifle OCD in these fossilised remains is amazingly high, especially in the sabre-toothed cat.
"This could indicate some degree of inbreeding, a factor which is predicated for species close to extinction.
TVM says DogStem, which is currently the only UK/EU-licensed stem cell treatment for this condition, is clinically proven to reduce pain and lameness while improving mobility and quality of life for dogs over one year.
The training materials include downloadable teaching guides and two videos fronted by Dr Russell Chandler BVSc CertSAO MSc(OrthoEng) MRCVS, an Advanced Practitioner in Small Animal Orthopaedics (pictured).
The videos are designed to help GP vets become more confident about performing intra-articular injections in the hip and elbow, sharing principles and techniques which are also useful for performing arthrocentesis.
Specifically, the videos show the precise procedures, in both elbow and hip, for accessing joint spaces, confirming accurate placement by the appearance of synovial fluid and injecting DogStem.
The training guides offer supporting diagrams and explanations of the approaches to each joint.
Russell, who works at Alphavet Referrals in Newport, Gwent said: “We are proud to have been involved in the production of these training videos, which will support veterinary clinicians everywhere in providing pioneering stem cell treatment to improve the quality of life of dogs suffering from osteoarthritis.
“We have been using mesenchymal stem cell therapy for dogs with osteoarthritis, as part of a multimodal approach, for many years.
"The availability of an off-the-shelf stem cell product, namely DogStem, for the first time promises to greatly widen the applicability of stem cell therapy to these kinds of patients in veterinary practices.
“The early responses to treatment that we have seen with DogStem have been very encouraging.
"I look forward to following up these cases as they progress through their osteoarthritis journey.
"DogStem is simple to administer, once you have the skills to inject joints, and the support from the UK suppliers, TVM, has been excellent."
https://dogstem.co.uk/resources
Visitors will be given a behind-the-scenes look and have the opportunity to chat with Specialist surgeons Former Member and Chris Jordan.
Andy said: “We have had a fantastic first six months, and to say thank you to those who have referred cases to us, and to show off our facilities to those who haven’t seen the clinic, we are thrilled to be holding an open evening.
"I’m looking forward to providing tours of the clinic and having a chance to talk to vets about our services and how we can help.”
All veterinary professionals and their families, and pet owners are welcome.
The clinic is situated just off the M3 and 30 minutes from the M25, in the village of Upton Grey, near Basingstoke.
To register your interest and book a place at the open day please contact Marie at Marie@mooresortho.com or 01256 632100.
Although the disease is commonly diagnosed later in life, a 2022 study of 123 dogs found that 40% of those aged between one and four years old had radiographic osteoarthritis, of which about half had clinical signs and of those only 2 were being treated for pain1.
Another 2022 study found that 38% of dogs over the age of one had osteoarthritic pain, but only half of them were presented for lameness or stiffness2.
Geoffrey Guyot, Pain and Inflammation Franchise Lead at Boehringer Ingelheim Animal Health, said: “Clinical signs of early osteoarthritis can be subtle.
"Some young dogs may present with overt lameness, but many compensate for years and manage to continue to perform their daily activities.
"Common compensations include gait or posture changes to unload the painful joint, which often go unnoticed.”
Boehringer says the aim of its campaign is to shift the perception of osteoarthritis as an old dog disease, to one which could affect dogs of all ages.
Boehringer also wants the campaign to bridge the gap between vets and dog owners, making it easier for owners to spot the early signs and initiate conversations about the condition.
Geoffrey added: "We hope the Arthritis AWARE campaign will raise awareness of early OA among owners to create more opportunities for you to diagnose and treat dogs with arthritis and improve their outcome.
"We encourage vet practices to join us on the journey so we can help improve dogs’ wellbeing together.”
Vet practices can help spread the word by downloading the Arthritis AWARE campaign pack which includes a waiting room video, a poster, owner-facing leaflets, and social media assets.
www.metacam.co.uk/aware
The 12-month surgical guarantee covers professional fees, including consultations, anaesthesia and surgery, involved in rectifying a complication as long as the patient is in good health and the post-surgery instructions have been followed appropriately.
Clinical Director, Andy Moores, an RCVS-Recognised Specialist in Small Animal Orthopaedics, said: “We can never promise that surgery will be free of complications, but we are confident in our low complication rate.
"We are offering a surgical guarantee to demonstrate this confidence and to provide our clients with the reassurance that we will help them get through any post-surgical complications.”
Andy added: “Along with our highly competitive fixed-price fees we hope this guarantee will give owners financial peace-of-mind when their pet needs orthopaedic treatment at this difficult time.
"We do not know of any other specialist orthopaedic centre in the southeast that offers better value care.”
For free case advice, email: advice@mooresortho.com
The company says the sessions will help veterinary staff learn more about the condition - which affects up to 20% of dogs in the UK annually1 - the causes and consequences of osteoarthritis pain, the main predisposing risk factors and the impact of chronic pain on central sensitisation.
The CPD will look at what steps practices can take to mitigate animal suffering and increase long-term owner compliance and will encourage practices to look at their current osteoarthritis management strategy.
Kai Crawshaw, Brand Manager at Animalcare, said: "Canine osteoarthritis is a growing concern for UK vets – latest figures suggest that over two million dogs are suffering, based on current population figures.
"Managing these cases can be challenging, but through this lunch and learn session, we aim to support veterinary staff and help them to expand their knowledge and implement an improved approach for managing canine osteoarthritis.’
www.animalcare.co.uk/lunch-and-learn
Movoflex contains eggshell membrane, hyaluronic acid, Astaxanthin, Boswellia serrata and krill meal, formulated to support joint health and help increase quality of life.
Virbac says that eggshell membrane, which has been shown to have an effect on mobility in dogs and humans1, contains a number of naturally occurring elements involved in joint structure and function, including collagen, glucosamine and chondroitin sulphate.
The company claims that one palatable Movoflex Soft Chew per day can lead to a perceived increase in mobility in 7 days 2, regardless of the activity levels or age of the dog.
This, the company says, compared to other supplements which can require multiple daily tablets to be given for up to six weeks before you start to see an effect.
Dan Johnson, Product Manager at Virbac said: ‘Movoflex Soft Chews offer pet owners an easy to give and reliable joint supplement, and as with all of Virbac’s joint health and mobility solutions, they are of the highest quality and developed based on science.’
Movoflex Soft Chews are available in Small (<15kg), Medium (15kg- 35kg) and Large Dog (35kg) packs, each containing 30 chews and are available to order from your usual veterinary wholesaler.
The study1, which was conducted by surgery resident Dr Charlie Brincin at Highcroft Veterinary Group (soon to be Bristol Vet Specialists) and orthopaedic surgeon Dr Matt Matiasovic at Manchester Vet Specialists, looked at the records of 825 dogs that had been treated surgically for unilateral MPL at 10 referral centres, and then had a planned follow-up visit, including radiographs.
The frequency of, and reasons for, changes in further recovery recommendations were investigated.
The findings demonstrated that if the dog made an uneventful2 recovery after surgery, was presented without owner concern, and if no abnormality was found on physical examination, then radiographic findings only led to a change in recommendation in 3% (13/432) of these dogs.
Researchers say that this reflects similar research on the influence of follow-up radiographs in human medicine, and those of previous veterinary studies on post-operative radiographs, following uncomplicated tibial plateau leveling osteotomy (TPLO). These particular studies3,4 showed radiography had an impact on post-operative management in just 2%-3.8% of cases.
As a result of the MPL and TPLO studies, Highcroft Veterinary Referrals and Manchester Veterinary Specialists will no longer systematically perform follow-up radiographs on their patients, unless justified clinically.
Charlie said: “Radiographs are not without additional costs or risks - including radiation exposure, sedation-associated risks and strain on veterinary staff.
"Radiographic intervention should be clinically justified and our study suggests that if the dog had an uneventful recovery and is presented without owner or clinician raised concern, then repeat radiographs might not be necessary.
"This study also highlights the value of a thorough owner history and clinical examination for clinical decision-making when re-examining dogs following this orthopaedic surgery.”
The MPL study also evaluated factors which significantly increased the risk of finding radiographic abnormalities at routine follow-up, and those which led to a change in post-operative recommendation.
Lameness, administration of analgesia at follow-up, and history of unplanned visits prior to routine re-examination were associated with increased odds of a change in postoperative plan (P < 0.001).
In the absence of owner and clinician concerns, the odds of having a change in convalescence plans were not different, whether or not isolated radiographic abnormalities were present (P = 0.641).
Andy (pictured right) will be joined at the The Moores Orthopaedic Clinic by fellow surgical specialist Chris Jordan, and Managing Director Richard Hoile.
The clinic is situated just off the M3, thirty minutes from the M25.
It is equipped with a CT scanner, mobile digital radiography and two surgical theatres with a full complement of orthopaedic kit including for total hip replacement in cats and all sizes of dogs.
To ensure best patient outcomes the surgical suite has its own HEPA-filtered ventilation system, isolated from the rest of the clinic, which Andy says exceeds guidelines for human orthopaedic theatres and will reduce the risk of infection.
Andy said: “The Moores Orthopaedic Clinic fills a gap in the market to provide high-class specialist orthopaedic care at a reasonable price.
"We have two very experienced specialist surgeons and a clinic designed from the ground-up to reduce the risk of complications after surgery.
"We will be able to provide the very best orthopaedic care and the best possible outcomes after surgery.
"And without the high overheads many referral centres often face, we will be able to achieve this at a very competitive price.
"I can’t wait to start seeing cases in May.”
Non-urgent cases can be booked from April 2023 using the online referral form: https://mooresortho.com/contact/
In the lead up to opening in May, Andy is available for remote consultations, client visits, to consult/operate on select cases in your own clinic or to discuss cases via email andy@mooresortho.com
mooresortho.com